HAE
Haemonetics Corp
Price:  
85.73 
USD
Volume:  
952,730.00
United States | Health Care Equipment & Supplies
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

HAE EV/EBITDA

15.5%
Upside

As of 2024-06-25, the EV/EBITDA ratio of Haemonetics Corp (HAE) is 16.57. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. HAE's latest enterprise value is 4,987.51 mil USD. HAE's TTM EBITDA according to its financial statements is 300.98 mil USD. Dividing these 2 quantities gives us the above HAE EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 15.7x - 17.0x 16.3x
Forward P/E multiples 20.0x - 23.9x 22.5x
Fair Price 80.69 - 121.57 99.03
Upside -5.9% - 41.8% 15.5%
85.73 USD
Stock Price
99.03 USD
Fair Price

HAE EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-06-24 16.57
2024-06-21 16.48
2024-06-20 16.53
2024-06-18 16.51
2024-06-17 16.55
2024-06-14 16.39
2024-06-13 16.62
2024-06-12 16.60
2024-06-11 16.18
2024-06-10 16.59
2024-06-07 16.55
2024-06-06 16.85
2024-06-05 17.10
2024-06-04 16.94
2024-06-03 16.45
2024-05-31 16.29
2024-05-30 16.39
2024-05-29 16.87
2024-05-28 17.12
2024-05-24 17.01
2024-05-23 17.06
2024-05-22 17.31
2024-05-21 17.83
2024-05-20 18.18
2024-05-17 18.26
2024-05-16 18.10
2024-05-15 18.39
2024-05-14 18.54
2024-05-13 18.34
2024-05-10 18.28
2024-05-09 17.73
2024-05-08 17.84
2024-05-07 18.17
2024-05-06 18.20
2024-05-03 18.04
2024-05-02 17.85
2024-05-01 17.65
2024-04-30 17.62
2024-04-29 17.55
2024-04-26 17.46
2024-04-25 16.90
2024-04-24 16.65
2024-04-23 16.46
2024-04-22 16.21
2024-04-19 15.81
2024-04-18 16.19
2024-04-17 16.43
2024-04-16 16.31
2024-04-15 16.43
2024-04-12 16.48